HKSE - Delayed Quote HKD
Pharmaron Beijing Co., Ltd. (3759.HK)
13.680
+0.160
+(1.18%)
At close: 4:08:06 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
2,683,854.955
2,576,656.397
2,753,538.935
2,142,816.417
2,058,043.830
Operating Cash Flow
--
2,576,656.397
2,753,538.935
2,142,816.417
2,058,043.830
Investing Cash Flow
-2,769,280.896
-2,024,279.702
-2,250,832.788
-2,208,542.127
-5,258,146.930
Financing Cash Flow
-3,383,000.326
-4,796,674.205
3,915,261.584
-1,417,263.709
3,661,394.942
End Cash Position
1,093,080.999
1,622,961.834
5,789,114.669
1,359,712.740
2,769,709.459
Capital Expenditure
-2,097,741.307
-2,040,641.186
-2,865,320.812
-2,949,861.152
-2,092,821.568
Issuance of Debt
1,366,072.368
1,321,965.262
4,170,876.932
589,811.983
4,621,423.607
Repayment of Debt
-3,722,342.636
-5,093,354.672
-559,136.522
-612,578.666
-158,554.797
Free Cash Flow
586,113.648
536,015.211
-111,781.877
-807,044.735
-34,777.737
12/31/2021 - 11/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6622.HK Zhaoke Ophthalmology Limited
1.740
+1.16%
1873.HK VIVA BIOTECH
1.510
+4.14%
1530.HK 3SBIO
12.260
+4.07%
2269.HK WuXi Biologics (Cayman) Inc.
23.100
+1.09%
KROS Keros Therapeutics, Inc.
14.26
+0.35%
9926.HK Akeso, Inc.
87.300
+0.11%
NTLA Intellia Therapeutics, Inc.
8.48
+2.05%
REGN Regeneron Pharmaceuticals, Inc.
610.86
+1.36%
BNTX BioNTech SE
104.00
+1.94%
MRNA Moderna, Inc.
27.46
+0.88%